Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Antisense NF-K p65 Oligonucleotide

EU orphan designation number: EU/3/02/106   
Active ingredient: Antisense NF-Kß p65 Oligonucleotide
Indication: Treatment of active ulcerative colitis
Sponsor: InDex Pharmaceuticals AB
Tomtebodavägen 23a, 171 77 Stockholm, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/08/2002 Orphan Designation EMEA/OD/014/02 (2002)3016 of 30/07/2002
03/11/2004 Change of address of sponsor
07/12/2011 Change of address of sponsor EMEA/OD/014/02
23/10/2012 Change of address of sponsor EMEA/OD/014/02
09/10/2014 Change of address of sponsor